[HTML][HTML] Design of a randomized placebo-controlled trial to evaluate the anti-inflammatory and senolytic effects of quercetin in patients undergoing coronary artery …
O Dagher, P Mury, PE Noly, A Fortier… - Frontiers in …, 2021 - frontiersin.org
Background: Following an acute coronary syndrome, patients display an elevated
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …
Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass …
O Dagher, P Mury, PE Noly, A Fortier, G Lettre… - Frontiers in …, 2021 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> Background:</jats: bold> Following an acute coronary syndrome,
patients display an elevated inflammatory profile, promoted in part by cellular senescence …
patients display an elevated inflammatory profile, promoted in part by cellular senescence …
[HTML][HTML] Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery …
O Dagher, P Mury, PE Noly, A Fortier… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background: Following an acute coronary syndrome, patients display an elevated
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …
Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass …
O Dagher, P Mury, PE Noly, A Fortier… - Frontiers in …, 2021 - europepmc.org
Background: Following an acute coronary syndrome, patients display an elevated
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …
Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass …
O Dagher, P Mury, PE Noly, A Fortier… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Following an acute coronary syndrome, patients display an elevated
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …
inflammatory profile, promoted in part by cellular senescence. For patients requiring a …